By proceeding, you agree to our Terms of Use and Privacy Policy.
Rules-Based Medicine (RBM), a Q2 Solutions Company, is the world’s leading multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device
29-01 September 2022
With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater.
Event Ended
USA
Paid
Boston